| 文迪雅治疗2型糖尿病的临床疗效观察 |
| |
| 引用本文： | 崔洪臣,田祥龙.文迪雅治疗2型糖尿病的临床疗效观察[J].海南医学,2006,17(8):19-20. |
| |
| 作者姓名： | 崔洪臣 田祥龙 |
| |
| 作者单位： | 天津市大港医院,天津,300270 |
| |
| 摘 要： | 目的 观察胰岛素增敏剂文迪雅治疗2型糖尿病的临床疗效。方法 对40例2型糖尿病患者在原有降糖治疗的基础上加服文迪雅治疗12周，观察治疗前后的血糖，糖基化血红蛋白，血脂及空腹胰岛素及C肽水平以及尿微量白蛋白排泄率的变化。结果 空腹血塘、餐后血糖，塘基化血红蛋白，甘油三醣，空腹胰岛素，C肽水平以及尿微量白蛋白排泄率治疗后较治疗前明显下降（P〈0．05）。结论 文迪雅联合其他降糖药可减低胰岛素抵抗．改善胰岛素敏感性．有效控制血糖．降低尿白蛋白排泄率。
|
| 关 键 词： | 马来酸罗格列酮 文迪雅 2型糖尿病 胰岛素抵抗 尿白蛋白排泄率 |
| 文章编号： | 1003-6350（2006）08-019-02 |
Effect of Rosiglitazone Malcate(Avandia) in Treating Type 2 Diabetes |
| |
| CUI Hong-chen, et al.Effect of Rosiglitazone Malcate(Avandia) in Treating Type 2 Diabetes[J].Hainan Medical Journal,2006,17(8):19-20. |
| |
| Authors: | CUI Hong-chen |
| |
| Institution: | Tianjin Dagang Hospital, Tianjin 300270 China |
| |
| Abstract: | Objective To evaluate the clinical efficacy of rosiglitazone in treating type 2 diabetes. Methods Forty patients with type 2 diabetes were treated with rosiglitazone 4mg, one tirn a day, for 12weeks based the last treatments. Observations were made on the changes of fast and postprandial blood glucose, HbAlc, blood lipid, fast insulin level, fast c peptide level and UAER. Results The fast glucose, postprandial blood glucose, HbAlc, fast insulin, fast c peptide level and UAER decreased significantly after rosiglitazone treatment (P<0.05). Conclusions Avandia may decrease insulin resistance, improve insulin sensitivity, control blood glucose effectively, decrease UAER. |
| |
| Keywords: | Rosiglitazone Malcate Avandia Type 2 diabetes insulin resistance UAER |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
